Usana Health Sciences
USNA
188 hedge funds and large institutions have $1.19B invested in Usana Health Sciences in 2019 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 72 increasing their positions, 53 reducing their positions, and 38 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 53
30% more call options, than puts
Call options by funds: $1.32M | Put options by funds: $1.01M
9.03% more ownership
Funds ownership: 51.98% → 61% (+9%)
5% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 38
1% less funds holding
Funds holding: 190 → 188 (-2)
18% less capital invested
Capital invested by funds: $1.46B → $1.19B (-$263M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$28.2M |
| 2 |
BlackRock
New York
|
+$25.5M |
| 3 |
Two Sigma Investments
New York
|
+$15.7M |
| 4 |
Man Group
London,
United Kingdom
|
+$14.9M |
| 5 |
Millennium Management
New York
|
+$13.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
-$16.8M |
| 2 |
Lazard Asset Management
New York
|
-$6.08M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
-$5.97M |
| 4 |
FL
Fort LP
Chevy Chase,
Maryland
|
-$5.15M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$5.01M |
USNA Hedge Fund Activity: Q1 2019 in Review
188 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2019, worth a combined $1.19B — down 18% from $1.46B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of USNA and 36 opened new positions — a net loss of 2 holders — while 53 trimmed existing stakes and 72 added.
The largest buyer was Morgan Stanley, adding an estimated $28.2M. The largest seller was TIAA CREF Investment Management, cutting an estimated $16.8M.
- 188 institutional investors held Usana Health Sciences (USNA) as of Q1 2019, down from 190 in Q4 2018.
- Funds reported $1.19B of Usana Health Sciences stock for Q1 2019, down 18% quarter-over-quarter.
- 36 funds opened new Usana Health Sciences positions in Q1 2019 and 38 closed out, a net change of -2 holders.
- The largest Usana Health Sciences buyer in Q1 2019 was Morgan Stanley, an estimated $28.2M added.
- The largest Usana Health Sciences seller in Q1 2019 was TIAA CREF Investment Management, an estimated $16.8M sold.
Based on aggregated 13F filings for Q1 2019.